NASDAQ NMS - GLOBAL MARKET · BDSX
+9.83% · +$1.98 · Vol 86.1K
Market closed · last close 4:00 PM ET · price as of 17:54:55 ET
Biodesix Inc

Biodesix Inc

Health Care
$22.13

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BDSX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for BDSX are being assembled.
About Biodesix Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2020
Employees
334
Country
US

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$20.22
Day high
$23.00
Day low
$20.12
Previous close
$20.15
52W high
$24.25
-8.74% from high
52W low
$15.01
77% of range
Market cap
$208.7M
EPS
$-2.1300
Shares out
10.4M
Volume
86.1K
VWAP
$21.68
Price history computed in-house
1W
+0.50%
1M
+45.11%
SMA 50 $19.19 · above
SMA 200 $19.19 · above
52W position 77%
Veridion warehouse edge

Warehouse intelligence for BDSX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BDSX insider activity

Biodesix Inc

Score
Coverage building
Pressure
Net buying
Filings
32
Buys / sells
7 / 25
Net value
$4.6M
Insiders
6
Named filers
VC
Vazquez Chris
Insider
Leadership
CH
Cowie Robin Harper
Insider
Leadership
HS
Hutton Scott
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $4.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-02-232026-02-23Vazquez ChrisInsidersell$12.782111,586$3KSEC Form 4
2026-02-232026-02-23Cowie Robin HarperInsidersell$12.7853516,231$7KSEC Form 4
2026-02-232026-02-23Hutton ScottInsidersell$12.781,49048,767$19KSEC Form 4
2026-02-232026-02-23Pestano Gary AnthonyInsidersell$12.7855610,359$7KSEC Form 4
2026-02-232026-02-23O'Kane KieranInsidersell$12.785359,819$7KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 27 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BDSX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BDSX in this window.
Lobbying spend

BDSX lobbying filings, year to date.

Registered lobbying filings matched to Biodesix Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BDSX in this window.
Latest news · BDSX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BDSX.
Options
Sovereign unlock shows live options positioning for BDSX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.